ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

PRXL Parexel International Corp.

88.08
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Parexel International Corp. NASDAQ:PRXL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 88.08 88.10 88.11 0 01:00:00

PAREXEL International Announces Date of Third Quarter Fiscal Year 2016 Earnings Release and Conference Call

24/03/2016 8:00pm

Business Wire


Parexel (NASDAQ:PRXL)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Parexel Charts.

PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter Fiscal Year 2016 on Wednesday, April 27th, 2016 after the close of the stock market.

PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, April 28th, 2016 to discuss the results. To access the webcast, visit the Investor Section of PAREXEL’s website at www.PAREXEL.com. This webcast will continue to be accessible for one year following the live broadcast. To participate via telephone, dial (408) 940-3886 and ask to join PAREXEL’s Third Quarter Fiscal Year 2016 conference call.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of expertise-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 77 locations in 51 countries around the world, and had approximately 18,200 employees in the second quarter. For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL International CorporationIngo Bank, Senior Vice President and Chief Financial OfficerInvestor Relations, + 1-781-434-4118IR@PAREXEL.com

1 Year Parexel Chart

1 Year Parexel Chart

1 Month Parexel Chart

1 Month Parexel Chart

Your Recent History

Delayed Upgrade Clock